Evogene News

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel, April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company de

PR NewswireApr 16 07:00 ET

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), Edwards Lifesciences (EW) and Nurix Therapeutics (NRIX)

TipRanksApr 11 07:50 ET

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....

PR NewswireApr 11 07:00 ET

Evogene's New Venture Targets Sustainable Protein Market

TipRanksApr 2 07:57 ET

Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry

Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology REHOVOT, Israel, April 2, 2024 /PRNewswire/ -

PR NewswireApr 2 07:00 ET

Evogene (EVGN) Receives a Buy From Lake Street

TipRanksApr 1 08:55 ET

Evogene Ltd. Announces $7.3 Million Share Sale Plan

TipRanksMar 28 21:30 ET

Evogene Announces Filing of Annual Report on Form 20-F

REHOVOT, Israel, March 28, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and d

PR NewswireMar 28 09:00 ET

Evogene Gets Non-compliance Notice From Nasdaq

Seeking AlphaMar 20 09:20 ET

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

PRNewswireMar 20 09:00 ET

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing

PRNewswireMar 19 09:00 ET

Earnings Call Summary | Evogene(EVGN.US) Q4 2023 Earnings Conference

The following is a summary of the Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript:Financial Performance:Evogene reported a significant increase in revenue, moving from approximately $1.7 million

moomoo AIMar 7 14:33 ET · Conference Call

Evogene Earnings Beat by $0.01, Revenue Fell Short of Estimates

InvestingMar 7 07:14 ET

Express News | Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate

Moomoo 24/7Mar 7 07:05 ET

Evogene 4Q Rev $578,000 >EVGN

Evogene 4Q Rev $578,000 >EVGN

Dow JonesMar 7 07:05 ET

Press Release: Evogene Reports Fourth Quarter and Full Year 2023 Financial Results

Evogene Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire REHOVOT, Israel, March 7, 2024 Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +9

Dow JonesMar 7 07:00 ET

Earnings Scheduled For March 7, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. • Stevanato Gr (NYSE:STVN) is likely to report quarte

BenzingaMar 7 04:49 ET

Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules

Evogene's (EVGN) AgPlenus unit said Wednesday that it achieved a milestone in its herbicide development collaboration with Corteva (CTVA) Agriscience after it identified a new family of molecules that

MT NewswiresMar 6 12:10 ET

Evogene Q4 2023 Earnings Preview

Seeking AlphaMar 6 10:28 ET

Express News | AgPlenus Achieves Milestone In Collaboration With Corteva To Develop Novel Herbicides

Moomoo 24/7Mar 6 07:07 ET